Gilead Sciences Inc (GILD)
93.89
+0.49
(+0.52%)
USD |
NASDAQ |
Dec 24, 13:00
93.89
0.00 (0.00%)
After-Hours: 13:59
Gilead Sciences Free Cash Flow: 9.431B for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc | 8.227B |
| Eli Lilly and Co | -2.275B |
| Merck & Co Inc | 14.84B |
| AbbVie Inc | 15.62B |
| Amgen Inc | 6.283B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 4.309B |
| Cash from Investing (Quarterly) | -710.00M |
| Cash from Financing (Quarterly) | -1.379B |
| Free Cash Flow Per Share (Quarterly) | 3.324 |
| Free Cash Flow to Equity (Quarterly) | 4.269B |
| Free Cash Flow to Firm (Quarterly) | 4.412B |
| Free Cash Flow Yield | 8.02% |